Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Pilot Study to Assess Safety and Biomarker Responses of Ritlecitinib (JAK3/TEC Inhibitor) in Cicatricial Alopecia

NCT05549934 is registered in ClinicalTrials.gov with Emma Guttman as lead sponsor.

NCT NCT05549934
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05549934 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Pilot Study to Assess Safety and Biomarker Responses of Ritlecitinib (JAK3/TEC Inhibitor) in Cicatricial Alopecia
Lead sponsor
Emma Guttman
Phase
Phase 2
Overall status
Completed
Start date
December 15, 2022
Completion date
March 20, 2025
Enrollment
50 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

cicatricial alopecia